100 related articles for article (PubMed ID: 21194031)
1. Lentiviral vector delivery of shRNA into cultured primary myogenic cells: a tool for therapeutic target validation.
Richard E; Douillard-Guilloux G; Caillaud C
Methods Mol Biol; 2011; 709():223-35. PubMed ID: 21194031
[TBL] [Abstract][Full Text] [Related]
2. Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II.
Douillard-Guilloux G; Raben N; Takikita S; Batista L; Caillaud C; Richard E
Hum Mol Genet; 2008 Dec; 17(24):3876-86. PubMed ID: 18782850
[TBL] [Abstract][Full Text] [Related]
3. Design and cloning of lentiviral vectors expressing small interfering RNAs.
Tiscornia G; Singer O; Verma IM
Nat Protoc; 2006; 1(1):234-40. PubMed ID: 17406238
[TBL] [Abstract][Full Text] [Related]
4. [Construction of a lentiviral vector for RNA interference of human CDH22 gene and its gene silencing effect in SW480 cells].
Zhou J; Li JM; Yang FD; Liu YH; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):589-92. PubMed ID: 18495598
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells.
Li M; Rossi JJ
Methods Mol Biol; 2005; 309():261-72. PubMed ID: 15990406
[No Abstract] [Full Text] [Related]
7. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.
Rubinson DA; Dillon CP; Kwiatkowski AV; Sievers C; Yang L; Kopinja J; Rooney DL; Zhang M; Ihrig MM; McManus MT; Gertler FB; Scott ML; Van Parijs L
Nat Genet; 2003 Mar; 33(3):401-6. PubMed ID: 12590264
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
10. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
11. Correction of glycogenosis type 2 by muscle-specific lentiviral vector.
Richard E; Douillard-Guilloux G; Batista L; Caillaud C
In Vitro Cell Dev Biol Anim; 2008; 44(10):397-406. PubMed ID: 18810562
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
Gu W; Payne E; Sun S; Burgess M; McMillan NA
Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
14. Knock-down of gene expression in hematopoietic cells.
Scherr M; Venturini L; Eder M
Methods Mol Biol; 2009; 506():207-19. PubMed ID: 19110629
[TBL] [Abstract][Full Text] [Related]
15. The RNA silencing technology applied by lentiviral vectors in oncology.
Sumimoto H; Kawakami Y
Methods Mol Biol; 2010; 614():187-99. PubMed ID: 20225045
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector engineering for anti-HIV RNAi gene therapy.
ter Brake O; Westerink JT; Berkhout B
Methods Mol Biol; 2010; 614():201-13. PubMed ID: 20225046
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
Li MJ; Rossi JJ
Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of tissue factor expression in endothelial cells by lentivirus mediated shRNA].
Xiong SL; Wang Q; Zheng L; Bao J; Huang XZ; Liu JZ; Zeng FY; Qiu YR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):682-7. PubMed ID: 18772506
[TBL] [Abstract][Full Text] [Related]
19. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells].
Liu YH; Li JM; Zhou J; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.
Dreyer JL
Methods Mol Biol; 2010; 614():3-35. PubMed ID: 20225033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
